$PTON

Morgan Stanley Just Downgraded Peloton Stock. Here's Why.

Morgan Stanley analyst Nathan Feather downgraded Peloton Interactive (PTON) to 'Underweight' and set a $4.50 price target, citing a 78% drop in customer additions from pandemic peaks and negative subscriber growth. Feather expects subscriber churn to hurt earnings, while Barchart also signals downside. The analyst notes a shift to brick-and-mortar gyms and rising interest in strength training as threats to Peloton's hardware revenue. Despite this, the consensus rating remains 'Moderate Buy' with

Original reporting
Published Sep 10, 2026, 6:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 6:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morgan Stanley Just Downgraded Peloton Stock. Here's Why. — source image
Decision brief

The 30-second read

$PTONBearishHigh
01

Why it matters

The downgrade may accelerate the stock's decline and influence peer valuations.

02

Market read

Analyst downgrade with a lower price target is a fresh catalyst for Peloton's price weakness.

03

What to watch

Potential cost‑cutting measures and new product launches could mitigate subscriber decline.

Relevance 7/10Novelty 7/10Timing: today

Background

Peloton has underperformed in 2026, down ~20% YTD, with subscriber growth turning negative.

Company-level read

Ticker impact

$PTONBearishHigh confidence
Context

Morgan Stanley downgraded Peloton to Underweight and cut its price target to $4.50, prompting a price decline.

Expected impact

Potential further downside of 5‑10% in the near term.

Evidence & confidence

Analyst cites 78% drop in new users and negative subscriber growth through 2029, which directly affects revenue.

Market effects

Connected‑fitness sector may face broader pressure as subscriber trends weaken.

U.S. consumer discretionary sentiment could dip.

Limited to Peloton and peers in home‑fitness equipment.

Counterpoint

Consensus remains a Moderate Buy with a mean target of $8.25, suggesting upside if the downgrade is overblown.

Key entities

  • Morgan Stanley

    Provided the downgrade and new price target.

  • Peloton Interactive

    Subject of the downgrade.

Related articles

$LMTMed

Stocks making the biggest moves premarket: Peloton Interactive, Roivant Sciences, Boston Scientific & more

Roivant Sciences (RVN) shares rose 24% after positive Phase 2 trial results for its pulmonary hypertension treatment. Novartis (NVS) fell 12% due to disappointing Phase 3 trial results. Peloton (PTON) dropped 4% following a Morgan Stanley downgrade. Boston Scientific (BSX) declined 2% after reporting a cyberattack impact. Bloom Energy (BE) gained 6% ahead of its S&P 500 inclusion. Quantum computing stocks rose on U.S. investment news.

$PTONMedAI 8/10

Why Peloton Stock Plummeted by 16% Last Month

Peloton (PTON) reported its first annual net profit of $63M for fiscal 2026, but stock fell 16% in August due to declining subscriptions and memberships. Q4 revenue was $608M, beating estimates, with subscription revenue up 7% YoY. Analyst Curtis Nagle cut price target to $7 from $7.50, citing subscriber trends.